Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Colorcon
Merck
Mallinckrodt
Dow

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Litigation Details for Galderma Laboratories, L.P. v. Perrigo UK FINCO L.P. (D. Del. 2016)

See Plans and Pricing

« Back to Dashboard

Galderma Laboratories, L.P. v. Perrigo UK FINCO L.P. (D. Del. 2016)

Docket   Start Trial Date Filed 2016-08-19
Court District Court, D. Delaware Date Terminated 2016-12-06
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties GALDERMA LABORATORIES, L.P.; NESTLE SKIN HEALTH S.A.; PERRIGO CO.; PERRIGO UK FINCO L.P.
Patents 7,439,241; 8,410,102; 8,426,410; 8,513,247; 8,513,249; 8,859,551
Attorneys Jack B. Blumenfeld; John C. Phillips , Jr.; Maryellen Noreika
Link to Docket External link to docket
Small Molecule Drugs cited in Galderma Laboratories, L.P. v. Perrigo UK FINCO L.P.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Galderma Laboratories, L.P. v. Perrigo UK FINCO L.P. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-08-19 1 United States Patent Nos. 7,439,241 (“the ’241 patent”); 8,426,410 (“the ’410 patent”); 8,859,551 (“… of the ’241 patent, the ’410 patent, the ’551 patent, the ’102 patent, the ’247 patent, and the ’249…1), the ’241 patent, the ’410 patent, the ’551 patent, the ’102 patent, the ’247 patent, and the ’249… of the ’241 patent, the ’410 patent, the ’551 patent, the ’102 patent, the ’247 patent, and the ’249… of the ’241 patent, the ’410 patent, the ’551 patent, the ’102 patent, the ’247 patent, and the ’249 External link to document
2016-08-19 3 Notice: July 7, 2016. Date of Expiration of Patent: 7,439,241 - August 25, 2025 10,102 - May 24, 2025 8,… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2016 6 December 2016 1:16-cv-00732 830 Patent None District Court, D. Delaware External link to document
2016-08-19 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,439,241 B2; 8,410,102 B2; 8,426,410…2016 6 December 2016 1:16-cv-00732 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Colorcon
Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.